Cases by country, the UK and NHS pathway and other country lenses, the expert centres with trials on record, and the centres named on this cancer's subtypes.
Site: Stomach. World: 980,286 new cases a year.
| # | Country | New cases | Incidence ASR |
|---|---|---|---|
| 1 | China | 341,966 | |
| 2 | Japan | 142,506 | |
| 3 | India | 68,548 | |
| 4 | Russian Federation | 42,346 | |
| 5 | Brazil | 28,323 | |
| 6 | United States of America | 27,638 | |
| 7 | Korea, Republic of | 27,423 | |
| 8 | Bangladesh | 17,830 | |
| 9 | Iran, Islamic Republic of | 14,595 | |
| 10 | Germany | 13,774 |
Country-level death counts mix every stage, subtype and year of diagnosis, and reflect access to screening and treatment as much as the disease. Survival differs by stage, subtype and year; the cancer page above leads with what can be done.
| # | Country | New cases | Deaths |
|---|---|---|---|
| 1 | China | 341,966 | 248,675 |
| 2 | Japan | 142,506 | 51,440 |
| 3 | India | 68,548 | 45,392 |
| 4 | Russian Federation | 42,346 | 26,728 |
| 5 | Brazil | 28,323 | 18,981 |
| 6 | United States of America | 27,638 | 11,148 |
| 7 | Korea, Republic of | 27,423 | 9,422 |
| 8 | Bangladesh | 17,830 | 15,151 |
| 9 | Iran, Islamic Republic of | 14,595 | 12,703 |
| 10 | Germany | 13,774 | 9,666 |
World: 980,286 new cases and 641,554 deaths a year (GLOBOCAN 2024).
Seoul · hospital | South Korea | none recorded | 0 | 1,292 | 17,512 | #3 | |
Seoul · hospital | South Korea | none recorded | 0 | 1,196 | 18,881 | none recorded | #4 |
Villejuif · cancer center | France | none recorded | 0 | 1,878 | 34,575 | #6 | |
Seoul · hospital | South Korea | none recorded | 0 | 1,540 | 22,259 | #8 | |
Baltimore · cancer center | United States | 0 | 3,313 | 48,889 | #10 | ||
Tokyo · government | Japan | none recorded | 0 | 1,329 | 21,303 | none recorded | #13 |
Heidelberg · cancer center | Germany | none recorded | 0 | 2,172 | 30,102 | #18 | |
Seoul · hospital | South Korea | none recorded | 0 | 860 | 12,793 | #22 | |
Tokyo · cancer center | Japan | none recorded | 0 | 1,081 | 9,967 | none recorded | #25 |
Milan · cancer center | Italy | none recorded | 0 | 1,384 | 18,166 | #27 | |
Beijing · cancer center | China | none recorded | 0 | 1,895 | 33,286 | none recorded | #50 |
Guangzhou · cancer center | China | none recorded | 0 | 2,020 | 26,080 | none recorded | #60 |
Shanghai · hospital | China | none recorded | 1 | 3,733 | 40,855 | - | |
Beijing · cancer center | China | none recorded | 1 | 1,521 | 17,126 | - | |
Goyang · cancer center | South Korea | none recorded | 1 | 737 | 10,060 | - |
These are the things we can measure; they are not a ranking of quality. Each column is a field on the institution record or a count over what OnCo has linked; a centre that treats many patients with Gastric & gastro-oesophageal junction cancer but is thinly recorded here will look small.
Not known: OnCo holds no case-volume or outcome figures for centres, so none are shown. Where a national audit or registry publishes them, the centre's page links to it. Default order: Newsweek rank, then trials for this cancer, then research output.
20 centres are named on one of the types below rather than on Gastric & gastro-oesophageal junction cancer itself. Grouped by the type that holds them; the full table for each sits on that type's page.